BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22255596)

  • 1. A disease annotation study of gene signatures in a breast cancer microarray dataset.
    Gypas F; Bei ES; Zervakis M; Sfakianakis S
    Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():5551-4. PubMed ID: 22255596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer classification: linking molecular mechanisms to disease prognosis.
    Taherian-Fard A; Srihari S; Ragan MA
    Brief Bioinform; 2015 May; 16(3):461-74. PubMed ID: 24950687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Merging microarray data from separate breast cancer studies provides a robust prognostic test.
    Xu L; Tan AC; Winslow RL; Geman D
    BMC Bioinformatics; 2008 Feb; 9():125. PubMed ID: 18304324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portraits of breast cancer progression.
    Dalgin GS; Alexe G; Scanfeld D; Tamayo P; Mesirov JP; Ganesan S; DeLisi C; Bhanot G
    BMC Bioinformatics; 2007 Aug; 8():291. PubMed ID: 17683614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable Gene Signature Selection for Prediction of Breast Cancer Recurrence Using Joint Mutual Information.
    Sehhati M; Mehridehnavi A; Rabbani H; Pourhossein M
    IEEE/ACM Trans Comput Biol Bioinform; 2015; 12(6):1440-8. PubMed ID: 26671813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays.
    Carlsson A; Wingren C; Ingvarsson J; Ellmark P; Baldertorp B; Fernö M; Olsson H; Borrebaeck CA
    Eur J Cancer; 2008 Feb; 44(3):472-80. PubMed ID: 18171612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient sample-oriented analysis of gene expression highlights extracellular signatures in breast cancer progression.
    Hong Y; Kim N; Li C; Jeong E; Yoon S
    Biochem Biophys Res Commun; 2017 May; 487(2):307-312. PubMed ID: 28412350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of two-stage SVM-RFE gene selection strategy for microarray expression data analysis.
    Tang Y; Zhang YQ; Huang Z
    IEEE/ACM Trans Comput Biol Bioinform; 2007; 4(3):365-81. PubMed ID: 17666757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivation of molecular signatures for breast cancer recurrence prediction using a two-way validation approach.
    Sun Y; Urquidi V; Goodison S
    Breast Cancer Res Treat; 2010 Feb; 119(3):593-9. PubMed ID: 19291396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved breast cancer prognosis through the combination of clinical and genetic markers.
    Sun Y; Goodison S; Li J; Liu L; Farmerie W
    Bioinformatics; 2007 Jan; 23(1):30-7. PubMed ID: 17130137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrinsic Subtypes of Primary Breast Cancer--Gene Expression Analysis.
    Schmidt M; Thomssen C; Untch M
    Oncol Res Treat; 2016; 39(3):102-10. PubMed ID: 27031354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer.
    Georgescu C; Corbin JM; Thibivilliers S; Webb ZD; Zhao YD; Koster J; Fung KM; Asch AS; Wren JD; Ruiz-Echevarría MJ
    BMC Cancer; 2019 May; 19(1):423. PubMed ID: 31060542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reply of the authors.
    Malcher A; Kurpisz MK
    Fertil Steril; 2014 May; 101(5):e32-3. PubMed ID: 24680365
    [No Abstract]   [Full Text] [Related]  

  • 14. An effective hybrid approach of gene selection and classification for microarray data based on clustering and particle swarm optimization.
    Han F; Yang S; Guan J
    Int J Data Min Bioinform; 2015; 13(2):103-21. PubMed ID: 26547970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Gene-Expression Signatures and Protein Markers for Breast Cancer Grading and Staging.
    Yao F; Zhang C; Du W; Liu C; Xu Y
    PLoS One; 2015; 10(9):e0138213. PubMed ID: 26375396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prototype for unsupervised analysis of tissue microarrays for cancer research and diagnostics.
    Chen W; Reiss M; Foran DJ
    IEEE Trans Inf Technol Biomed; 2004 Jun; 8(2):89-96. PubMed ID: 15217253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of early breast cancer patient survival using ensembles of hypoxia signatures.
    Gong IY; Fox NS; Huang V; Boutros PC
    PLoS One; 2018; 13(9):e0204123. PubMed ID: 30216362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomedical application of fuzzy association rules for identifying breast cancer biomarkers.
    Lopez FJ; Cuadros M; Cano C; Concha A; Blanco A
    Med Biol Eng Comput; 2012 Sep; 50(9):981-90. PubMed ID: 22622817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel secretome-to-transcriptome integrated or secreto-transcriptomic approach to reveal liquid biopsy biomarkers for predicting individualized prognosis of breast cancer patients.
    Ankney JA; Xie L; Wrobel JA; Wang L; Chen X
    BMC Med Genomics; 2019 May; 12(1):78. PubMed ID: 31146747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple SVM-RFE for gene selection in cancer classification with expression data.
    Duan KB; Rajapakse JC; Wang H; Azuaje F
    IEEE Trans Nanobioscience; 2005 Sep; 4(3):228-34. PubMed ID: 16220686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.